semaglutide in heart failure Patients With Obesity and Across Mildly Reduced or Preserved Ejection Fraction US study confirms cardiovascular benefits

It is not an FDA-approved protocol

doi:10.1002/jcph.443

Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (dis CoVeRy): a phase 3, randomised, controlled, open-label trial

Patients typically notice improved energy, better sleep, increased muscle tone, and fat loss within a few weeks, with full benefits developing over 3 to 6 months

This selectivity profile made it particularly attractive for clinical development and is the primary reason it became the most widely used GHRP in the peptide therapy space

Emerging research is also exploring their potential effects on the brain, including whether they can help reduce cravings for drugs, alcohol and nicotine